Immage Biotherapeutics Corp.
IMMG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.17K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $15,174.00 |
|---|---|
| Enterprise Value | $-128,767.00 |
| Earnings per Share | $0 |
| Beta | 0.01 |
| Outstanding Shares | 151,744,566 |
Return
| Return on Equity | -512.77% |
|---|---|
| Return on Assets | -126.16% |
| Return on Invested Capital | -8180.64% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | 0.07 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.7 |
| Debt to Equity | -4.04 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Immage Biotherapeutics Corp.
3 employees
CEO: Zhi Cong Mou
Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States....